Skip to main navigation Skip to search Skip to main content

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score

  • Andrea De Luca
  • , Simona Di Giambenedetto
  • , R Maserati
  • , N Gianotti
  • , P Narciso
  • , A Antinori
  • , G Di Perri
  • , Mcf Prosperi
  • , F Baldanti
  • , V Micheli
  • , M Zazzi
  • , Cf Perno
  • , Mm Santoro
  • Azienda Ospedaliera Universitaria Senese

Research output: Contribution to journalArticle

Abstract

There is not yet consensus on interpretation of genotypic HIV-1 resistance to darunavir (DRV). We validated existing rules and a newly derived score.
Original languageEnglish
Pages (from-to)489-497
Number of pages9
JournalAntiviral Therapy
Volume16
Issue number4
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Algorithms
  • Anti-HIV Agents
  • Combination
  • Drug Resistance
  • Drug Therapy
  • Genotype
  • HIV Infections
  • HIV Protease Inhibitors
  • HIV-1
  • Humans
  • Microbial Sensitivity Tests
  • Predictive Value of Tests
  • Ritonavir
  • Sulfonamides
  • Treatment Outcome
  • Viral

Fingerprint

Dive into the research topics of 'Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score'. Together they form a unique fingerprint.

Cite this